GLP-1 Drugs Drive Low-ABV Drink Trend in Restaurants

Last year, a major restaurant group reported a 15% increase in non-alcoholic beverage sales, even as their traditional cocktail revenue flattened. A clear preference among diners for alternatives to alcoholic drinks is signaled by this shift. Such a change challenges established revenue streams.

Consumer demand for traditional high-margin alcoholic beverages declines, but the opportunity for premium, innovative non-alcoholic alternatives expands rapidly. This tension exists between established profit models and evolving diner expectations.

Restaurants failing to adapt their beverage and food strategies to these evolving health and wellness trends risk significant revenue loss and market irrelevance annually. The interplay of GLP-1 medications and the low-ABV movement drives this shift in restaurant menu trends by 2026.

A recent survey found that 40% of GLP-1 users reported significantly reduced alcohol cravings, according to a Novo Nordisk Study. A rapid shift in consumer behavior is revealed by this finding. Concurrently, non-alcoholic beverage sales at fine dining establishments grew 25% year-over-year, according to Restaurant Business Online. The trend is confirmed by this growth. However, one major restaurant chain observed a 10% dip in average check size for tables ordering zero alcoholic drinks, even with increased food orders, as reported by DineStats Report. Such shifts impact overall revenue per table, moving away from traditional alcoholic beverages.

The Wellness Wave: How GLP-1s and Low-ABV Are Reshaping Dining

Prescriptions for GLP-1 agonists like Ozempic and Wegovy surged by over 300% between 2020 and 2023, according to IQVIA Data. Dietary choices are influenced by this medical advancement. Concurrently, the global market for non-alcoholic beverages is projected to reach $1.7 trillion by 2030, an increase from $1.1 trillion in 2022, according to Grand View Research. A broader cultural movement towards wellness is reflected by this growth. Further, 65% of Gen Z consumers report actively trying to reduce their alcohol intake, according to a NielsenIQ Consumer Survey. Users of GLP-1 medications often report a decreased desire for rich, fatty foods and sugary drinks, a finding noted in the Journal of Clinical Endocrinology & Metabolism. A powerful new consumer demographic, demanding distinct dining preferences in both beverage and food, is created by this convergence of medical and cultural shifts.

Craft breweries and distilleries focused solely on high-ABV products experience stagnant growth, with some reporting declining sales, according to the Brewers Association. This contrasts sharply. Companies specializing in premium non-alcoholic spirits and beers saw their market share grow by 20% in 2025, according to Beverage Industry Magazine. Restaurants successfully introducing dedicated non-alcoholic tasting menus report a 5-8% increase in customer satisfaction scores, according to Zagat Reviews. Conversely, traditional bar-centric establishments struggle to adapt, with some reporting a 10-15% drop in peak-hour beverage revenue, a trend observed by Bar & Restaurant News. The industry bifurcates, rewarding innovators and those catering to new health trends, while penalizing establishments slow to adapt.